India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,545 SS Vanangamudi ₹1,300 Cr
Revenue · FY 2025
₹834.88 Cr
▲ 7% YoY
Net profit · FY 2025
₹8.02 Cr
Net margin 1%
EBITDA · FY 2025
₹55.27 Cr
EBITDA margin 6.6%
Authorised capital
₹2.75 Cr
Registered with MCA
Paid-up capital
₹1.83 Cr
Issued & subscribed
Open charges
₹160.27 Cr
Satisfied ₹486.97 Cr
Company age
48 yrs
Est. 1978
Employees · EPFO
3,633
Provident fund records
About Apex Laboratories Private Limited
Data last updated:
Apex Laboratories Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 July 1978 and has been in existence for over 48 years.
Its director SS Vanangamudi is #1,545 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85195TN1978PTC007554. Its GSTIN is 33AAACA5174G1Z0 (Tamil Nadu).
The company has an authorised share capital of ₹2.75 Cr and a paid-up capital of ₹1.83 Cr. It was formerly known as Apex Laboratories Limited. It is led by directors including Sulur Vanangamudi Subramaniam (Managing Director) and Sulur Ponmudi Vigneswaran (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 3rd Floor SIDCO Garment Complex Guindy, Chennai, Tamil Nadu, India – 600032.
As per the financials filed for FY 2025, the company reported a revenue of ₹834.88 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹8.02 Cr (net margin 1%) and EBITDA of ₹55.27 Cr (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 10% over five years.
The company has about 3,633 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Apex. As per MCA filings, the company has open charges of ₹160.27 Cr and satisfied charges of ₹486.97 Cr on record. Court records list 352 cases involving the company, including 261 filed by the company and 91 filed against it; 66 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apexlab.com.
Company details
CIN U85195TN1978PTC007554
Registration Number 007554
Incorporation Date 15 July 1978
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
CIN history
Apex Laboratories has one previous CIN (Corporate Identification Number): U85195TN1978PLC007554. The current CIN is U85195TN1978PTC007554, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85195TN1978PTC007554 | Current |
| U85195TN1978PLC007554 | Previous |
Key People
Sulur Vanangamudi Subramaniam Managing Director Sulur Ponmudi Vigneswaran Whole-Time Director Srinivasan Murali Director Recognitions & Rankings of Apex Laboratories
Contact details
Apex Laboratories Private Limited's registered office is in Chennai, Tamil Nadu. Its website is apexlab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3rd Floor SIDCO Garment Complex Guindy, Chennai, Tamil Nadu, India – 600032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Apex Laboratories Private Limited, buy the company report.
Comprehensive company report
Apex Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Apex Laboratories operates one associated brand: apex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, marketing, and export of formulations based in India. | apexlab.com |
Business activity
The main business activity of Apex Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Apex Laboratories Private Limited, buy the company report.
Financials of Apex Laboratories Private Limited
FY 2024 filings availableApex Laboratories Private Limited reported revenue of ₹834.88 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹834.88 Cr ▲ 7%
Net profit · FY 2025
₹8.02 Cr margin 1%
EBITDA · FY 2025
₹55.27 Cr margin 6.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▼ 1%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 36%
5 years · compounded
▼ 6%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 7% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹55.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.02 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apex Laboratories Private Limited, buy the company report.
Board of directors of Apex Laboratories Private Limited
Apex Laboratories has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasan Murali | Director | 01 Sep 2022 | 4 Years 1 Months | Current |
| Swaminathan | Director | 03 Sep 1982 | 44 Years 1 Months | Current |
| Thangavelu Mannavan Also directs: M Chandru Organics Private Limited | Director | 14 May 2014 | 12 Years 5 Months | Current |
| Sulur Vanangamudi Subramaniam | Managing Director | 03 Feb 1982 | 44 Years 8 Months | Current |
| Vishagan Also directs: Vanan Pharma Private Limited, Halez Hospitality Services Private Limited, Apex Exports Private Limited and 1 more | Director | 11 Oct 2019 | 7 Years 0 Months | Current |
| Sulur Ponmudi Vigneswaran Also directs: Subramaniam Chemicals and Explosives Private Limited | Whole-Time Director | 01 Oct 2012 | 14 Years 0 Months | Current |
Peer comparison
Apex Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rubicon Research Limited | ₹872.39 Cr (FY 2024) | 108.0% | Thane, Maharashtra, India | |||
| Fresenius Kabi Oncology Limited | ₹848.26 Cr (FY 2025) | 4.0% | New Delhi, Delhi, India | |||
| Scott Edil Pharmacia Limited | ₹847.96 Cr (FY 2025) | 7.0% | Chandigarh, India | |||
| Bliss GVS Pharma Limited | ₹846.22 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Apex Laboratories Private Limitedthis company | ₹834.88 Cr (FY 2025) | ₹8.02 Cr | 1% | 7.0% | 3,633 | Chennai, Tamil Nadu, India |
| Gufic Biosciences Limited | ₹823.43 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Synokem Pharmaceuticals Limited | ₹791.15 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Prime Pharmaceuticals Private Limited | ₹783.06 Cr (FY 2025) | 131.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Apex Laboratories Private Limited, buy the company report.
Auditor
Apex Laboratories Private Limited is audited by RAVI & RAGHU for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI & RAGHU | FY 2024 | 005060S |
Shareholding
The shareholding of Apex Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apex Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹160.27 Cr
Satisfied charges
₹486.97 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2025 | 101158716 | Hdfc Bank Limited | ₹1.23 Cr | Open | |
| 07 Aug 2025 | 101146782 | Bank of India | ₹18 Lakh | Open | |
| 29 Apr 2025 | 101091289 | Axis Bank Limited | ₹7 Cr | Open | |
| 17 Apr 2025 | 101091814 | Hdfc Bank Limited | ₹2.5 Cr | Open | |
| 19 Mar 2025 | 101079007 | Others | ₹30 Cr | Open |
To see the full charge records of Apex Laboratories Private Limited, buy the company report.
Total charge records: 71 View all charges
Legal cases
Apex Laboratories Private Limited has 352 court cases on record: 261 filed by Apex Laboratories, 91 filed against it. 66 cases are pending and 286 are disposed.
Total cases
352
Filed by the company
261
Filed against the company
91
Pending
66
Disposed
286
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 321 | 66 | 48 |
| District courts | 24 | 21 | 13 |
| NCLAT | 4 | 4 | 4 |
| Supreme Court | 3 | 0 | 1 |
Cases on record (5 of 352)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Interim or miscellaneous application | Filed by the company against F.G.Pharma Private Limited, | Pending |
| Madras High Court | Court case (OSA(CAD)) | Filed by the company against F.G. Pharma Private Limited | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Gufic Biosciences Limited & Anr. | Pending |
| Madras High Court | Appeal | Filed against the company by F.G.Pharma Private Limited | Pending |
| Madras High Court | Court case (C.S(COMM DIV)) | Filed against the company by F.G.Pharma Private Limited | Pending |
To see the full case history of Apex Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Apex Laboratories Private Limited was last rated by Care on 30 Mar 2026.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 30 Mar 2026 |
To see the full credit ratings and regulatory alerts of Apex Laboratories Private Limited, buy the company report.
MSME payment delays
Apex Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 153 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 45)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bagavathi Amman Print Pack | |||
| an individual supplier | |||
| Swiss Garniers Biotech Private Limited | |||
| Almin Extrusion | |||
| Kranal Prints |
To see the full MSME payment records of Apex Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Apex Laboratories has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Apex Laboratories Private Limited has a workforce of 3,633 employees on its EPFO records as of Dec 23, 2025, across 1 active EPFO establishment.
Employee count
3,633
Active EPFO establishments
1
Employee growth
2.69%
GST
Apex Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACA5174G1Z0 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apex Laboratories Private Limited, buy the company report.
Recent activity
Apex Laboratories Private Limited has 13 board changes on record since 1982: 6 appointments and 7 cessations. The latest: Srinivasan Murali was appointed as Director on 01 Sep 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.23 Cr with Charge ID 101158716 was registered on 30 Aug 2025.
Charges
A charge with Standard Chartered Bank of Rs. 45.00 Cr registered on 24 Mar 2011 with Charge ID 10279094 was modified on 19 Aug 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.18 Cr with Charge ID 101146782 was registered on 07 Aug 2025.
Charges
A charge registered on 30 Sep 2021 via Charge ID 100493881 with Axis Bank Limited was fully satisfied on 22 May 2025.
Charges
A charge registered on 13 Dec 2019 via Charge ID 100312678 with Others was fully satisfied on 06 May 2025.
Charges
A charge registered on 22 Apr 2022 via Charge ID 100590147 with Hdfc Bank Limited was fully satisfied on 05 May 2025.
Charges
A charge registered on 30 Sep 2021 via Charge ID 100492087 with Axis Bank Limited was fully satisfied on 30 Apr 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 7.00 Cr with Charge ID 101091289 was registered on 29 Apr 2025.
Charges
A charge registered on 13 Feb 2020 via Charge ID 100325394 with Standard Chartered Bank was fully satisfied on 21 Apr 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.50 Cr with Charge ID 101091814 was registered on 17 Apr 2025.
Charges
A charge with Others of Rs. 30.00 Cr registered on 19 Mar 2025 with Charge ID 101079007 was modified on 16 Apr 2025.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101079007 was registered on 19 Mar 2025.
158 earlier events are in the company report.
News
Frequently asked questions
Apex Laboratories is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 July 1978 (48+ years old) and is registered under CIN U85195TN1978PTC007554.
Apex Laboratories has 6 current directors:
- Sulur Vanangamudi Subramaniam - Managing Director
- Sulur Ponmudi Vigneswaran - Whole-Time Director
- Srinivasan Murali - Director
- Swaminathan - Director
- Thangavelu Mannavan - Director
- Vishagan - Director
The latest financial statements of Apex Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Apex Laboratories is 33AAACA5174G1Z0, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Apex Laboratories is U85195TN1978PTC007554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apex Laboratories has 352 court cases on record: 261 filed by the company and 91 filed against it. 66 are pending. Most are in the high courts.
Apex Laboratories was incorporated on 15 July 1978, making it 48+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Apex Laboratories by revenue are Rubicon Research Limited, Fresenius Kabi Oncology Limited, Scott Edil Pharmacia Limited, Bliss GVS Pharma Limited, Gufic Biosciences Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Srinivasan Murali was appointed as Director on 01 Sep 2022. Srinivasan Murali ceased to be Director on 13 Oct 2021. Vishagan was appointed as Director on 11 Oct 2019. Apex Laboratories has 13 board changes on record in total.
Apex Laboratories has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 153 overdue payments to 45 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Apex Laboratories can be reached through the website apexlab.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Apex Laboratories is at 3rd Floor SIDCO Garment Complex Guindy, Chennai, Tamil Nadu, India – 600032.